Tobramycin 1.2 GM vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KF9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,784
Award facts
- Contract value 100% obligated
- $2,784.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,784.00 to AmerisourceBergen Drug Corp for the supply of Tobramycin 1.2 GM vials, with a completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. Tobramycin is an aminoglycoside antibiotic commonly used to treat serious bacterial infections, including those in military medical settings. The company's federal contract portfolio demonstrates extensive capability in delivering a broad range of pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. AmerisourceBergen's role as a primary vendor under the DLA Troop Support Medical IDC reflects its significant capacity to support the Defense Health Agency and other federal healthcare systems with essential medications and medical supplies.
Quick answers
Who was awarded contract SPE2DR26F9KF9?
SPE2DR26F9KF9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9KF9 worth?
The government has obligated $2,784 on SPE2DR26F9KF9.
Is contract SPE2DR26F9KF9 an order under another contract?
Yes. SPE2DR26F9KF9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KF9 competed?
The extent of competition for SPE2DR26F9KF9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award